top of page
Incubate Coalition Japan Statement on the Release of the Honebuto and Japan Growth Strategy
TOKYO, JP: Incubate Coalition Japan (ICJ) welcomes the Takaichi Cabinet's approval of the Basic Policy on Economic and Fiscal Management and Reform (Honebuto) and the Japan Growth Strategy. Together, these policies recognize life sciences innovation as a strategic driver of economic growth and signal Japan's intention to strengthen its position as a destination for global investment and scientific leadership. "Early-stage investors allocate capital globally, and they allocate
A Historic Opportunity: What the Takaichi–Trump Summit Must Deliver for Biotech
This week, Japanese Prime Minister Sanae Takaichi will visit Washington for a summit with President Trump. The meeting represents a pivotal moment for the US-Japan alliance, and for the global biopharmaceutical ecosystem that both countries depend on to drive medical innovation and protect patients. At Incubate Coalition Japan, we believe the summit is an opportunity to advance a critical but often overlooked agenda: ensuring that the policy environment in Japan supports the
ICJ Pushes for Policies That Support Investment and Innovation in Japan’s Life Sciences
Over the last several years, Incubate Coalition Japan (ICJ) has remained committed to its mission of promoting policies that empower life...
Strengthening the Trans-Pacific Life Sciences Partnership: Incubate in Japan
May 14-17, 2024 in Tokyo, Japan Incubate Participants: Dr. Sascha Berger, General Partner, TVM Capital Dr. Claire Leurent, Managing...
Incubate’s Statement On FY2024 NHI Drug Pricing System Reform Framework
This week, the Central Social Insurance Medical Council (“Chuikyo”) finalized the FY2024 National Health Insurance Drug Pricing System...
bottom of page